MSH3 and neoplasm: Nevertheless, changes in the MSH3 exon 1 polymorphism genotype were observed in tumor tissue compared to the corresponding normal mucosa, manifesting as loss of heterozygosity (LOH), which was observed in 27.4% (26/95) of the informative samples.